Your GLP-1 Program Dropped Compounded Medication? What to Do Next (2026)

It usually arrives as a cheerful email: your program is “simplifying its offerings,” your compounded medication is being discontinued, and you’re invited to continue on the brand version. In 2026 this has happened to a lot of people at once, as several of the largest telehealth platforms moved to brand-only GLP-1 menus. If that email just landed in your inbox: you have more options than the one it offers, and none of them require panic.

First: you have more runway than the email implies

Check how much medication you actually have on hand and when your last shipment arrives. Most program shutdowns fulfill existing orders, which typically leaves you two to six weeks of runway — enough time to make a considered decision instead of a same-day one. Use it. The worst outcome here isn’t paying more; it’s a multi-week gap in treatment that unwinds your progress and, if long enough, means re-titrating from a lower dose when you do continue.

Your four real options

• Pay for brand. Brand-name medication is a legitimate path — an FDA-approved finished product, available through the manufacturers’ own self-pay programs or a retail pharmacy with a prescription.
• Switch to another compounded program. Compounded GLP-1s remain available in 2026 through licensed pharmacies when prescribed for an individual patient — our guide to the 2026 regulatory landscape explains the rules. The switching process matters more than the destination; see below.
• Talk to your insurance. Coverage is narrowing, but if your employer plan covers GLP-1s for your situation, brand-with-coverage is often the simplest path. Expect prior-authorization paperwork — our coverage guide walks the appeal and self-pay options in order.
• Plan a deliberate off-ramp. If you’re near goal and considering stopping anyway, do it on purpose with a maintenance plan — not because a program email forced the timing. Our guide on what happens when you stop tirzepatide covers what to expect.

If you switch: the one thing to verify before you pay

The failure mode that costs people the most progress is being treated as a brand-new patient: restarted at the starter dose, working back up over months, feeling the appetite return in between. Before you pay any new program, confirm their intake asks what you were taking, at what dose, and where you left off — and that a licensed provider will build your plan from that history. The provider always makes the final dosing call, but a program whose intake never asks is telling you how it treats transfers. We wrote a full guide to switching GLP-1 providers without starting over, including the records worth having ready.

Watch the price structure, not just the price

Displaced patients are shopping under time pressure, which is exactly when pricing tricks work best. Two structures to check before the checkout page: whether the advertised price survives dose increases (many programs price by dose, so the number you see is the starter-dose number), and whether a “membership” fee rides on top of the medication price. Our teardown of hidden fees in GLP-1 telehealth lists the patterns.